We performed HER2 determination of CTCs using the CellSearch® System according to predefined criteria by Riethdorf et al., which were based on extensive validation experiments that used breast cancer cell lines with a known HER2 gene amplification status (as previously described)[21]. Here, ERBB2 is linked to breast carcinoma.